A comparative study of varying doses of enoxaparin for thromboprophylaxis in critically ill patients: double-blinded, randomised controlled trial. Critical care, 2013, 17: R75.
Robinson, S., et al.
http://ccforum.com/content/17/2/R75/abstract
Critically ill patients are predisposed to venous thromboembolism. We hypothesized that higher doses of enoxaparin would improve thromboprophylaxis without increasing the risk of bleeding.
No comments:
Post a Comment